Media coverage about LifePoint Health (NASDAQ:LPNT) has been trending positive recently, Accern Sentiment Analysis reports. The research firm identifies negative and positive press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. LifePoint Health earned a coverage optimism score of 0.43 on Accern’s scale. Accern also assigned news articles about the company an impact score of 47.2403660088002 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Here are some of the news stories that may have impacted Accern Sentiment’s rankings:

LPNT has been the topic of several analyst reports. Credit Suisse Group initiated coverage on shares of LifePoint Health in a report on Thursday, November 2nd. They issued a “neutral” rating and a $54.00 price target on the stock. ValuEngine lowered shares of LifePoint Health from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Zacks Investment Research raised shares of LifePoint Health from a “sell” rating to a “hold” rating in a report on Monday, September 11th. Leerink Swann reaffirmed an “outperform” rating and issued a $58.00 target price (down previously from $74.00) on shares of LifePoint Health in a report on Tuesday, October 31st. They noted that the move was a valuation call. Finally, SunTrust Banks set a $60.00 target price on shares of LifePoint Health and gave the stock a “hold” rating in a report on Thursday, October 12th. Two investment analysts have rated the stock with a sell rating, twelve have issued a hold rating and five have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of $60.23.

LifePoint Health (NASDAQ:LPNT) traded up $0.40 on Monday, hitting $49.00. 197,900 shares of the stock traded hands, compared to its average volume of 423,068. The company has a current ratio of 1.85, a quick ratio of 1.65 and a debt-to-equity ratio of 1.24. LifePoint Health has a fifty-two week low of $42.50 and a fifty-two week high of $70.95. The company has a market cap of $1,950.00, a price-to-earnings ratio of 11.61, a price-to-earnings-growth ratio of 1.27 and a beta of 0.67.

LifePoint Health (NASDAQ:LPNT) last posted its earnings results on Friday, October 27th. The company reported $0.80 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.95 by ($0.15). The firm had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.60 billion. LifePoint Health had a return on equity of 7.01% and a net margin of 2.45%. The firm’s revenue for the quarter was down .7% compared to the same quarter last year. During the same period in the previous year, the company posted $0.94 EPS. sell-side analysts predict that LifePoint Health will post 3.64 EPS for the current fiscal year.

LifePoint Health declared that its Board of Directors has initiated a stock buyback program on Friday, October 27th that authorizes the company to buyback $200.00 million in outstanding shares. This buyback authorization authorizes the company to reacquire shares of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s leadership believes its shares are undervalued.

In related news, Director Marguerite Kondracke sold 3,416 shares of the company’s stock in a transaction dated Tuesday, November 21st. The shares were sold at an average price of $43.80, for a total transaction of $149,620.80. Following the transaction, the director now owns 17,479 shares in the company, valued at approximately $765,580.20. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 8.76% of the stock is owned by corporate insiders.

COPYRIGHT VIOLATION WARNING: This news story was reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of international copyright laws. The legal version of this news story can be read at

LifePoint Health Company Profile

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Insider Buying and Selling by Quarter for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with's FREE daily email newsletter.